Tetanus
- PMID: 3516553
Item in Clipboard
Tetanus
Compr Ther.
1986 Apr.
Abstract
Tetanus is produced by the action of the potent neurotoxin, tetanospasmin, which is elaborated during the growth of Clostridium tetani. The objectives of management of tetanus are to provide supportive care until the tetanospasmin that is fixed in tissue has been metabolized, to neutralize circulating toxin, and to remove the source of tetanospasmin. This disease, which is frequently fatal, is prevented by immunization.
Similar articles
-
Current concepts in the management of Clostridium tetani infection.Expert Rev Anti Infect Ther. 2008 Jun;6(3):327-36. doi: 10.1586/14787210.6.3.327. Expert Rev Anti Infect Ther. 2008. PMID: 18588497 Review.
-
Management and prevention of tetanus.J Long Term Eff Med Implants. 2003;13(3):139-54. J Long Term Eff Med Implants. 2003. PMID: 14516181 Review.
-
Tetanus in the United States (1965-1966):epidemiologic and clinical features.N Engl J Med. 1969 Mar 13;280(11):569-74. doi: 10.1056/NEJM196903132801101. N Engl J Med. 1969. PMID: 4885059 No abstract available.
-
Tetanus: a team disease.Curr Probl Surg. 1972 Oct:3-72. doi: 10.1016/s0011-3840(72)80008-x. Curr Probl Surg. 1972. PMID: 4563143 No abstract available.
-
[Tetanus and Clostridium tetani--a brief review].Med Monatsschr Pharm. 2015 Feb;38(2):57-60. Med Monatsschr Pharm. 2015. PMID: 26376540 Review. German.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical